Overview of current targeted therapy in gallbladder cancer

X Song, Y Hu, Y Li, R Shao, F Liu, Y Liu - Signal Transduction and …, 2020 - nature.com
Gallbladder cancer (GBC) is rare, but is the most malignant type of biliary tract tumor.
Unfortunately, only a small population of cancer patients is acceptable for the surgical …

A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop

P Sharma, K McQuaid, J Dent, MB Fennerty… - Gastroenterology, 2004 - Elsevier
Background & Aims: The diagnosis and management of Barrett's esophagus (BE) are
controversial. We conducted a critical review of the literature in BE to provide guidance on …

[图书][B] WHO classification of tumours of the digestive system.

FT Bosman, F Carneiro, RH Hruban, ND Theise - 2010 - cabidigitallibrary.org
This book is the third volume of the 4th Edition of the WHO series on histological and genetic
typing of human tumours. It is an authoritative, concise reference book providing an …

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

BJ Reid, LJ Prevo, PC Galipeau… - Official journal of the …, 2001 - journals.lww.com
OBJECTIVES: Most patients with Barrett's esophagus do not progress to cancer, but those
who do seem to have markedly increased survival when cancers are detected at an early …

Barrett's esophagus: correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma

BJ Reid, RC Haggitt, CE Rubin, PS Rabinovitch - Gastroenterology, 1987 - Elsevier
The value of endoscopic surveillance biopsy for dysplasia and carcinoma in patients with
Barrett's esophagus is controversial. One reason is that the available histologic criteria are …

p53 and neoplastic progression in Barrett's esophagus

BJ Reid - Official journal of the American College of …, 2001 - journals.lww.com
With completion of the human genome sequence, we now have our first clear look at the
target organ for neoplastic disease. However, the conceptual framework for understanding …

TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort

L Murray, A Sedo, M Scott, D McManus, JM Sloan… - Gut, 2006 - gut.bmj.com
Background and aims: Oesophageal adenocarcinoma frequently develops on a background
of metaplastic Barrett's epithelium. The development of malignancy is accompanied by …

Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

H Shimada, A Takeda, M Arima, S Okazumi… - Cancer, 2000 - Wiley Online Library
BACKGROUND Patients with superficial (mucosal or submucosal) esophageal carcinoma
(SEC) have significantly better survival rates than patients with advanced carcinoma. Some …

AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease

R Dorer, RD Odze - The American journal of surgical pathology, 2006 - journals.lww.com
Abstract α-Methylacyl-CoA racemase (AMACR) catalyzes the racemization of α-methyl,
branched carboxylic coenzyme A thioesters, and is overexpressed in a variety of neoplasms …

Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma

S Takeno, T Noguchi, R Kikuchi… - … Journal of the …, 2002 - Wiley Online Library
BACKGROUND It has been reported that p53 regulates the G2‐M checkpoint transition
through cyclin B1, and it has been suggested that p53 plays an important role in the …